Below is information on how Dupixent works to treat asthma. How a medication works is also called its mechanism of action. Note: Dupixent should not be used to treat an asthma attack. The ...

Pharmaceuticals, a leading biotechnology company with a market capitalization of $73.94 billion, finds itself at a critical juncture as it navigates challenges to its flagship Eylea franchise while ...

Pharmaceuticals, a leading biotechnology company with a market capitalization of $73.8 billion, has been navigating a complex ...

Dupixent continues to be a significant growth ... targets a large market opportunity in thrombosis treatment. While the mechanism isn't fully de-risked and requires large, expensive Phase III ...

“Having Dupixent as the gold standard for AD ... GlobalData sharing their excitement about the progress of anti-OX40L mechanism of action. Overall, the positive outcomes from the clinical ...

The use of Dupixent in AD has set a high benchmark ... pharmaceutical companies are investigating agents with different mechanisms of action to provide alternatives to the current standard of ...

Enrollment of Part A completed ahead of schedule and exceeded enrollment target with 123 patients enrolledPart A 16-week proof-of-concept data ...

The success of Dupixent has demonstrated the viability ... With its innovative mechanism of action and established success in asthma, Fasenra could address critical safety and efficacy gaps ...

The company bagged FDA approval for first-in-class dual phosphodiesterase (PDE) 3/4 inhibitor Ohtuvayre (ensifentrine) last June, becoming the first inhaled product with a novel mechanism of ...

The drug’s mechanism of action simultaneously inhibits IL-4 and IL-13, which Sanofi says makes it a powerful treatment for type 2 inflammation in multiple diseases. Dupixent has already picked ...

Apogee begins patient dosing in Part B of phase 2 APEX trial of APG777 to treat moderate-to-severe atopic dermatitis: San Francisco Tuesday, February 4, 2025, 18:00 Hrs [IST] Apog ...